Results 281 to 290 of about 811,244 (395)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Polysomes of bovine anterior pituitary gland and their role in hormone and protein biosynthesis.
P. R. Adiga +4 more
openalex +1 more source
ABSTRACT We discuss the intricate relationship between the evolution of the concept of stress and the development of the concept of animal welfare. After a brief review of the main concepts of animal welfare, we analyse important steps in the evolution of the concept of stress, starting from the mechanistic approach of the General Adaptation Syndrome ...
Feifan Wu +3 more
wiley +1 more source
TWO METABOLICALLY ACTIVE PEPTIDES FROM PORCINE PITUITARY GLANDS
E. B. Astwood +2 more
openalex +1 more source
This study highlights the importance of germline genetic markers in predicting severe trAEs caused by nivolumab. Our findings support their potential to guide personalized immunotherapy and improve treatment safety and efficacy in advanced ccRCC and other cancers.
Tokiyoshi Tanegashima +26 more
wiley +1 more source
FOXO1 regulates expression of Neurod4 in the pituitary gland. [PDF]
Stallings CE +5 more
europepmc +1 more source
Granular-Cell Myoblastoma of the Pituitary Gland in an Old Rat: A Case Report
G. J. V. Swaen, A E Becker
openalex +1 more source
Reprimo (RPRM): A Tumor Suppressor That Induces Extrinsic Apoptosis via YAP Signaling
Reprimo (encoded by RPRM) is a p53 target gene that acts as a tumor suppressor and is frequently silenced by promoter hypermethylation in various cancers. Although previously known to function intracellularly as a tumor suppressor, recent studies revealed that secreted Reprimo also induces apoptosis in neighboring cells through a novel p53‐Reprimo ...
Masahiro Takikawa, Rieko Ohki
wiley +1 more source
The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors. [PDF]
Casar-Borota O, Burman P, Lopes MB.
europepmc +1 more source
ABSTRACT Objective Oral estrogens increase the levels of cortisol binding globulin (CBG) potentially affecting test results for adrenal insufficiency. The objective was to evaluate the influence of oral and transdermal estradiol on total plasma (p) and salivary cortisol in hypogonadal women with secondary adrenal insufficiency or at risk of developing ...
Laura S. Aagaard +4 more
wiley +1 more source

